SMITH & NEPHEW PLC (SNN) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding and 1 fund trimming or exiting versus the previous quarter. Latest close $30.32 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.
Causeway Capital Management — 1 tracked fund hold SNN. See all holders.
No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.
INTUITIVE SURGICAL INC (ISRG) · ZIMMER BIOMET HOLDINGS, INC. (ZBH) · Edwards Lifesciences Corp (EW) · ESTABLISHMENT LABS HOLDINGS INC. (ESTA) · MSA Safety Inc (MSA) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Causeway Capital Management | 0.49% | 1,565,167 | ADDED (+64.2%) Q3 filed Nov 13 |
| Saturna Capital | — | — | EXITED |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: +6.2% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 293 of 8,857 filers |
| Long-only filers among them | 293 |
| Change vs 2026 Q1 | +18 net · 284 entered · 266 exited |
| Shares reported, all filers | 36,521,876 |
| Reported value, all filers | $1.0B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | NYSE |
| Industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842) |
| Net income · FY2025 | $625.0M |
| Total assets · FY2025 | $10.5B |
| Shares outstanding | 877,724,845 |
| Market cap (at latest close) | $26.6B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Dec 31, 2025.
| Shares short · Oct 15, 2026 | 4,040,249 |
| Share of shares outstanding | 0.46% |
| Days to cover | 3.12 |
Shares short at recent settlements — Jul 31, 2026: 5.1M · Aug 14, 2026: 4.9M · Aug 31, 2026: 6.2M · Sep 15, 2026: 4.8M · Sep 30, 2026: 4.7M · Oct 15, 2026: 4.0M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Dec 31, 2025.
| Shares failed to deliver · Oct 14, 2026 | 13,987 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.3% |
Fails to deliver at recent settlements — Jul 31, 2026: 51K · Aug 14, 2026: 62K · Aug 31, 2026: 8K · Sep 15, 2026: 0 · Sep 30, 2026: 15K · Oct 14, 2026: 14K.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Dec 31, 2025.
Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.
| Filed | Form | Price change since disclosure |
|---|---|---|
| Jul 27, 2026 | SCHEDULE 13D/A | -6.3% (close Jul 28, 2026 → Nov 17, 2026) |
Reference close is the first trading day after the filing (Jul 28, 2026). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Jul 27, 2026 | Cevian Capital II GP Limited | SC 13D/A | 119,179,419 | 14.2% | Jul 23, 2026 | SEC filing |
| Jun 24, 2026 | Cevian Capital II GP Limited | SC 13D/A | 110,804,501 | 13.1% | Jun 22, 2026 | SEC filing |
| Jun 3, 2026 | Cevian Capital II GP LTD | SC 13D/A | 101,046,788 | 11.9% | Jun 1, 2026 | SEC filing |
| May 4, 2026 | Cevian Capital II GP LTD | SC 13D/A | 91,462,095 | 10.7% | Apr 30, 2026 | SEC filing |
| Mar 16, 2026 | Cevian Capital II GP LTD | SC 13D/A | 81,687,136 | 9.6% | Mar 12, 2026 | SEC filing |
| Jun 16, 2025 | Cevian Capital II GP Limited | SC 13D/A | 74,469,925 | 8.5% | Jun 12, 2025 | SEC filing |
| Apr 23, 2025 | BlackRock, Inc. | SC 13G/A | 63,497,743 | 7.3% | Mar 31, 2025 | SEC filing |
| Feb 19, 2025 | Cevian Capital II GP Limited | SC 13D/A | 65,480,254 | 7.5% | Feb 14, 2025 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.
None of the members who traded this stock in the current window sit on these committees.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Lobbying: no Lobbying Disclosure Act filings matched for this ticker (1999–2026).
Federal contracts: $4.7M in obligated amounts, fiscal years 2021–2026.
| Fiscal year | Obligated amount |
|---|---|
| FY2021 | $520.0K |
| FY2022 | $1.8M |
| FY2023 | $1.9M |
| FY2024 | $568.0K |
| FY2025 | $0 |
| FY2026 | $0 |
Largest awards collected
| Award ID | Agency | Amount | Start |
|---|---|---|---|
| 36C26120P1246 | Department of Veterans Affairs | $609.8K | Sep 21, 2020 |
| 36C26122P0730 | Department of Veterans Affairs | $375.0K | Apr 11, 2022 |
| HT001419F0212 | Department of Defense | $293.2K | Feb 13, 2019 |
| 36C25021N0339 | Department of Veterans Affairs | $167.4K | Feb 10, 2021 |
| 36C25720P1418 | Department of Veterans Affairs | $164.9K | Sep 4, 2020 |
Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.
This stock does not currently pass any tracked screen.
Also held by the tracked funds that hold SNN — ranked by lift, the co-holding pattern described in Methodology: INTUITIVE SURGICAL INC (ISRG) · ZIMMER BIOMET HOLDINGS, INC. (ZBH) · Edwards Lifesciences Corp (EW) · ESTABLISHMENT LABS HOLDINGS INC. (ESTA) · MSA Safety Inc (MSA) · STERIS plc (STE) · ALIGN TECHNOLOGY INC (ALGN) · Enovis CORP (ENOV).
8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.
No Form 8-K filings for this ticker in the index (Jan 2023 – present).
INTUITIVE SURGICAL INC (ISRG) · Track Record: how the signals scored · Practice timing on SNN
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.